Healthcare provider profile · identity verified

Mandeep Dhilon, MD

Family Practice · MIFFLINTOWN, PA · NPI 1649726423

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	172
Omeprazole	Omeprazole	437	128
Levothyroxine Sodium	Levothyroxine Sodium	406	103
Lisinopril	Lisinopril	331	102
Amlodipine Besylate	Amlodipine Besylate	282	85
Losartan Potassium	Losartan Potassium	258	79
Gabapentin	Gabapentin	249	76
Rosuvastatin Calcium	Rosuvastatin Calcium	226	78
Furosemide	Furosemide	209	60
Metoprolol Succinate	Metoprolol Succinate	192	64
Jardiance	Empagliflozin	181	41
Albuterol Sulfate Hfa	Albuterol Sulfate	169	64
Metformin Hcl	Metformin Hcl	157	51
Hydrochlorothiazide	Hydrochlorothiazide	156	49
Trazodone Hcl	Trazodone Hcl	148	46
Sertraline Hcl	Sertraline Hcl	145	43
Metformin Hcl Er	Metformin Hcl	139	49
Duloxetine Hcl	Duloxetine Hcl	127	31
Pantoprazole Sodium	Pantoprazole Sodium	123	35
Montelukast Sodium	Montelukast Sodium	120	33
Eliquis	Apixaban	113	24
Simvastatin	Simvastatin	109	35
Metoprolol Tartrate	Metoprolol Tartrate	107	36
Buspirone Hcl	Buspirone Hcl	100	31
Lorazepam	Lorazepam	98	18
Citalopram Hbr	Citalopram Hydrobromide	97	32
Glipizide Er	Glipizide	92	21
Alendronate Sodium	Alendronate Sodium	89	18
Meloxicam	Meloxicam	89	31
Venlafaxine Hcl Er	Venlafaxine Hcl	89	17
Alprazolam	Alprazolam	86	18
Ozempic	Semaglutide	86	20
Tamsulosin Hcl	Tamsulosin Hcl	85	27
Ezetimibe	Ezetimibe	83	28
Carvedilol	Carvedilol	81	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	19
Pregabalin	Pregabalin	80	17
Fluticasone Propionate	Fluticasone Propionate	78	36
Famotidine	Famotidine	76	19
Prednisone	Prednisone	75	57
Atenolol	Atenolol	74	21
Pravastatin Sodium	Pravastatin Sodium	70	19
Tramadol Hcl	Tramadol Hcl	63	20
Finasteride	Finasteride	61	18
Diclofenac Sodium	Diclofenac Sodium	57	21
Escitalopram Oxalate	Escitalopram Oxalate	56	18
Fluoxetine Hcl	Fluoxetine Hcl	53	15
Clopidogrel	Clopidogrel Bisulfate	52	16
Hydroxyzine Hcl	Hydroxyzine Hcl	49	17
Potassium Chloride	Potassium Chloride	48	15
Warfarin Sodium	Warfarin Sodium	48	16
Allopurinol	Allopurinol	47	16
Januvia	Sitagliptin Phosphate	47	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	18
Trulicity	Dulaglutide	46	suppressed
Azithromycin	Azithromycin	45	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	11
Mounjaro	Tirzepatide	44	suppressed
Azelastine Hcl	Azelastine Hcl	42	20
Baclofen	Baclofen	40	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	13
Bupropion Xl	Bupropion Hcl	34	13
Torsemide	Torsemide	34	12
Fenofibrate	Fenofibrate,micronized	33	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	11
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Topiramate	Topiramate	31	12
Novolog Flexpen	Insulin Aspart	30	suppressed
Jantoven	Warfarin Sodium	29	11
Nystatin	Nystatin	29	16
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Primidone	Primidone	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Tradjenta	Linagliptin	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lactulose	Lactulose	22	suppressed
Methocarbamol	Methocarbamol	22	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Repaglinide	Repaglinide	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Fluconazole	Fluconazole	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Ramipril	Ramipril	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Ibu	Ibuprofen	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Naproxen	Naproxen	17	11
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Bethanechol Chloride	Bethanechol Chloride	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	13
Clonazepam	Clonazepam	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Levoxyl	Levothyroxine Sodium	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error